---
name: tooluniverse-drug-regulatory
description: >
  Drug regulatory and approval research -- FDA substance registry lookup, drug classification
  by ATC/EPC/MoA via RxClass, Orange Book generic availability and patent status, DailyMed
  label parsing (adverse reactions, dosing, contraindications), and clinical trial search.
  Use when users ask about FDA-approved drugs, drug regulatory status, generic availability,
  patent expiration, drug class membership, drug labeling, or substance identification.
triggers:
  - keywords: [FDA, Orange Book, generic drug, UNII, RxClass, ATC code, drug class, NDA, ANDA, patent, exclusivity, DailyMed, drug label, adverse reactions, regulatory, approval]
  - patterns: ["FDA approved", "generic available", "patent expiration", "drug class", "ATC code", "Orange Book", "DailyMed", "drug labeling", "UNII"]

license: MIT License
metadata:
    skill-author: ToolUniverse (https://github.com/mims-harvard/TxAgent)
---

# Drug Regulatory Research

Regulatory intelligence for drugs: identify FDA substances, classify drugs by therapeutic
category, check approval and generic status, retrieve label sections, and find clinical trials.

## When to Use

- "What is the FDA regulatory status of semaglutide?"
- "Is there a generic for Humira?"
- "What ATC class does metformin belong to?"
- "Get adverse reactions from the ibuprofen drug label"
- "When does the patent for Eliquis expire?"
- "List all drugs in the ACE inhibitor class"
- "Find clinical trials for a biosimilar of adalimumab"

## NOT for (use other skills instead)

- Drug-drug interactions -> Use `tooluniverse-drug-drug-interaction`
- Pharmacogenomics / dosing by genotype -> Use `tooluniverse-pharmacogenomics`
- Drug mechanism of action / target binding -> Use `tooluniverse-drug-mechanism-research`
- Drug repurposing / new indications -> Use `tooluniverse-drug-repurposing`

---

## Workflow Overview

```
Input (drug name / brand name / UNII)
  |
  v
Phase 1: Substance Identification  -- FDAGSRS_search_substances, FDAGSRS_get_substance
  |
  v
Phase 2: Drug Classification       -- RxClass_get_drug_classes, RxClass_find_classes
  |
  v
Phase 3: Approval & Generic Status -- FDA_OrangeBook_search_drug, FDA_OrangeBook_check_generic_availability
  |
  v
Phase 4: Patent & Exclusivity      -- FDA_OrangeBook_get_patent_info, FDA_OrangeBook_get_exclusivity
  |
  v
Phase 5: Label Parsing             -- DailyMed_parse_adverse_reactions, DailyMed_parse_dosing, etc.
  |
  v
Phase 6: Clinical Trials           -- search_clinical_trials
  |
  v
Phase 7: Pharmacovigilance         -- FAERS_count_reactions_by_drug_event (param: medicinalproduct)
  |
  v
Phase 8: Literature & Approval     -- PubMed_search_articles, OpenFDA_get_approval_history, RxNorm_get_drug_names
```

> **Supplementary tools** (not in core phases but useful):
> - `OpenFDA_get_approval_history` — full FDA submission/approval history (requires `operation` param)
> - `FAERS_count_reactions_by_drug_event` — top adverse events by report count (param: `medicinalproduct`, ALL CAPS)
> - `RxNorm_get_drug_names` — resolve drug to RXCUI and brand names
> - `drugbank_vocab_search` — DrugBank ID, CAS, UNII lookup
> - `PubMed_search_articles` — regulatory and clinical literature

---

## Key Identifiers

| Data Type | Format | Example |
|-----------|--------|---------|
| FDA substance | UNII (10 chars) | R16CO5Y76E (aspirin) |
| RxNorm drug | RXCUI (numeric string) | "41493" (metformin) |
| ATC code | Letter-digit hierarchy | A10BA02 (metformin) |
| NDA application | NDA###### | NDA020402 |
| ANDA application | ANDA###### | ANDA078516 |
| DailyMed label | SPL Set ID (UUID) | 030d9bca-a934-6ef9-... |

---

## Phase 1: Substance Identification (FDAGSRS)

**FDAGSRS_search_substances**: `query` (string REQUIRED -- drug name, UNII, InChIKey, or formula), `substance_class` (string, optional: "chemical"/"protein"/"nucleic acid"/"polymer"/"mixture"), `limit` (int, 1-50, default 10).
Returns `{status, data: {substances: [{unii, name, substance_class, status, cross_references: [{type, value}]}]}}`.
- `cross_references` contains DrugBank IDs, WHO-ATC codes, CAS numbers, CFR citations.
- Use to get the official UNII identifier before calling `FDAGSRS_get_substance`.

**FDAGSRS_get_substance**: `unii` (string REQUIRED, 10-char FDA UNII code).
Returns complete substance record including all synonyms, names, structure, and cross-references.
- Provides definitive list of all registered names (INN, USAN, brand, chemical).

**FDAGSRS_get_structure**: `unii` (string REQUIRED).
Returns `{status, data: {smiles, formula, inchikey, molfile, molecular_weight, stereochemistry, optical_activity}}`.
- Only works for chemical substances; returns error for biologics, mixtures, polymers.

```python
# Full substance lookup workflow
search = tu.tools.FDAGSRS_search_substances(query="semaglutide")
unii = search["data"]["substances"][0]["unii"]
full = tu.tools.FDAGSRS_get_substance(unii=unii)
```

---

## Phase 2: Drug Classification (RxClass)

**RxClass_get_drug_classes**: `drug_name` (string, drug name), `rxcui` (string, RxNorm RXCUI -- alternative to drug_name), `rela_source` (string, optional: "ATC"/"FDASPL"/"MESH"/"VA"), `limit` (int, default 20).
Returns `{status, data: {classes: [{class_id, class_name, class_type, rela}]}}`.
- Returns ALL classification systems unless `rela_source` filters to one.
- `class_type` values: "ATC1-4", "EPC" (FDA Established Pharmacologic Class), "MoA", "VA", "MESH".
- Use to find a drug's ATC code, pharmacological class, mechanism of action label.

**RxClass_find_classes**: `query` (string REQUIRED, keyword e.g., "beta blocker"), `class_type` (string, optional: "ATC1-4"/"EPC"/"MoA"), `limit` (int, default 20).
Returns matching drug classes with class IDs.
- Use when you need to find a class ID before calling `RxClass_get_class_members`.

**RxClass_get_class_members**: `class_id` (string REQUIRED, e.g., "M01AE"), `rela_source` (string, optional: "ATC"/"FDASPL"), `ttys` (string, optional: "IN" for ingredients), `limit` (int, default 50).
Returns all drug ingredients in the class with RXCUIs and names.
- `ttys="IN"` restricts to active ingredient-level entries (recommended).

```python
# Find all proton pump inhibitors
classes = tu.tools.RxClass_find_classes(query="proton pump inhibitor", class_type="EPC")
class_id = classes["data"]["classes"][0]["class_id"]
members = tu.tools.RxClass_get_class_members(class_id=class_id, ttys="IN")
```

---

## Phase 3: Approval & Generic Status (FDA Orange Book)

**FDA_OrangeBook_search_drug**: `brand_name` (string), `generic_name` (string), `application_number` (string), `limit` (int, default 10).
Returns `{status, data: {products: [{brand_name, generic_name, dosage_form, strength, te_code, application_number, approval_date}]}}`.
- Use brand name (UPPERCASE) or generic name to find NDA/ANDA numbers and approval info.
- `te_code`: Therapeutic Equivalence code (e.g., "AB" = therapeutically equivalent).

**FDA_OrangeBook_check_generic_availability**: `brand_name` (string), `generic_name` (string).
Returns `{status, data: {reference_listed_drug, generics_available: bool, generics_count, generic_products: [...]}}`.
- Primary tool for "is there a generic?" questions.

**FDA_OrangeBook_get_te_code**: No special params beyond `brand_name`/`application_number`.
Returns therapeutic equivalence codes for substitutability assessment.

**FDA_OrangeBook_get_approval_history**: `application_number` (string, e.g., "NDA020402").
Returns chronological approval history including supplemental approvals and label changes.

```python
# Check generic availability
result = tu.tools.FDA_OrangeBook_check_generic_availability(brand_name="LIPITOR")
# result["data"]["generics_available"] -> True
# result["data"]["generics_count"] -> N
```

---

## Phase 4: Patent & Exclusivity

**FDA_OrangeBook_get_patent_info**: `application_number` (string), `brand_name` (string).
Returns patent information. Note: Full patent numbers and expiration dates require Orange Book data files.

**FDA_OrangeBook_get_exclusivity**: `application_number` (string), `brand_name` (string).
Returns `{status, data: {exclusivities: [{exclusivity_code, exclusivity_date, description}]}}`.
- `exclusivity_code` values: "NCE" (New Chemical Entity, 5 years), "ODE" (Orphan Drug, 7 years), "PED" (Pediatric, 6 months), "NP" (New Product), "M" (new formulation).

---

## Phase 5: Label Parsing (DailyMed)

All DailyMed parse tools accept either `setid` (SPL Set ID UUID) OR `drug_name` (auto-lookup).
Using `drug_name` is recommended when the setid is unknown.

**DailyMed_parse_adverse_reactions**: `setid` or `drug_name`. Returns structured adverse reaction table with frequencies and severity.

**DailyMed_parse_dosing**: `setid` or `drug_name`. Returns dosage and administration section (doses, schedules, renal/hepatic adjustments).

**DailyMed_parse_contraindications**: `setid` or `drug_name`. Returns contraindications section.

**DailyMed_parse_drug_interactions**: `setid` or `drug_name`. Returns drug-drug interaction section with clinical management guidance.

**DailyMed_parse_clinical_pharmacology**: `setid` or `drug_name`. Returns PK/PD data (Cmax, AUC, half-life, protein binding, metabolism pathway).

**DailyMed_search_spls**: `drug_name` (string), returns SPL Set IDs for that drug. Use to find `setid` when needed explicitly.

```python
# Parse adverse reactions for apixaban
ae = tu.tools.DailyMed_parse_adverse_reactions(drug_name="apixaban")
```

---

## Phase 6: Clinical Trials

**search_clinical_trials**: `condition` (string), `intervention` (string), `query_term` (string), `pageSize` (int, alias: `max_results`/`limit`), `overall_status` (array, alias: `status`).
Returns `{status, data: {studies: [{NCT ID, brief_title, brief_summary, overall_status, phase}], total_count}}`.
- Use `intervention` for drug name, `condition` for disease.
- Filter `overall_status=["RECRUITING"]` for active enrollment.
- `total_count` may be None even when results exist; check `len(studies) > 0`.

```python
# Find recruiting trials for a biosimilar
trials = tu.tools.search_clinical_trials(
    intervention="adalimumab biosimilar",
    overall_status=["RECRUITING"],
    pageSize=10
)
```

---

## Tool Quick Reference

| Tool | Key Params | Returns |
|------|-----------|---------|
| FDAGSRS_search_substances | `query`, `substance_class`, `limit` | UNII + substance class + cross-refs |
| FDAGSRS_get_substance | `unii` | All names, references, structure |
| FDAGSRS_get_structure | `unii` | SMILES, InChIKey, MW, stereochemistry |
| RxClass_get_drug_classes | `drug_name` or `rxcui`, `rela_source` | ATC/EPC/MoA/VA classifications |
| RxClass_find_classes | `query`, `class_type` | Class IDs + names |
| RxClass_get_class_members | `class_id`, `rela_source`, `ttys` | Drug ingredients in class |
| FDA_OrangeBook_search_drug | `brand_name`/`generic_name`/`application_number` | Products + NDA + TE codes |
| FDA_OrangeBook_check_generic_availability | `brand_name` or `generic_name` | Generic status + count |
| FDA_OrangeBook_get_exclusivity | `application_number` or `brand_name` | Exclusivity codes + dates |
| FDA_OrangeBook_get_approval_history | `application_number` | Chronological approval events |
| DailyMed_parse_adverse_reactions | `drug_name` or `setid` | AE table with frequencies |
| DailyMed_parse_dosing | `drug_name` or `setid` | Dosage and administration |
| DailyMed_parse_contraindications | `drug_name` or `setid` | Contraindications list |
| DailyMed_parse_drug_interactions | `drug_name` or `setid` | DDI section |
| DailyMed_parse_clinical_pharmacology | `drug_name` or `setid` | PK/PD data |
| search_clinical_trials | `condition`, `intervention`, `pageSize`, `overall_status` | NCT studies |

---

## Example Workflows

### Workflow 1: Full Regulatory Profile for a Drug

```
1. FDAGSRS_search_substances(query="apixaban")
   -> UNII, substance class, ATC/DrugBank cross-refs

2. RxClass_get_drug_classes(drug_name="apixaban", rela_source="ATC")
   -> ATC code B01AF02 (direct factor Xa inhibitor)

3. FDA_OrangeBook_search_drug(brand_name="ELIQUIS")
   -> NDA206518, approval date, TE code

4. FDA_OrangeBook_check_generic_availability(brand_name="ELIQUIS")
   -> Generic availability status

5. FDA_OrangeBook_get_exclusivity(brand_name="ELIQUIS")
   -> Exclusivity codes and expiration dates

6. DailyMed_parse_adverse_reactions(drug_name="apixaban")
   -> Bleeding rates and other AEs from label
```

### Workflow 2: List All Drugs in a Therapeutic Class

```
1. RxClass_find_classes(query="ACE inhibitor", class_type="EPC")
   -> class_id for "Angiotensin-Converting Enzyme Inhibitor"

2. RxClass_get_class_members(class_id=<id>, ttys="IN")
   -> All ACE inhibitors (enalapril, lisinopril, ramipril, etc.)

3. For each drug: RxClass_get_drug_classes(drug_name=drug)
   -> Confirm ATC code and additional classifications
```

### Workflow 3: Drug Label Review

```
1. DailyMed_parse_adverse_reactions(drug_name="metformin")
   -> AE frequencies (GI: lactic acidosis, nausea, diarrhea)

2. DailyMed_parse_contraindications(drug_name="metformin")
   -> eGFR thresholds, renal impairment contraindications

3. DailyMed_parse_drug_interactions(drug_name="metformin")
   -> Iodinated contrast, carbonic anhydrase inhibitor interactions

4. DailyMed_parse_clinical_pharmacology(drug_name="metformin")
   -> Half-life, renal clearance, bioavailability
```

---

## Common Mistakes to Avoid

| Mistake | Correction |
|---------|-----------|
| Using lowercase for Orange Book `brand_name` | Use UPPERCASE (e.g., "LIPITOR" not "lipitor") |
| Passing drug name to FDAGSRS_get_substance | Requires UNII code; use FDAGSRS_search_substances first |
| Expecting full patent numbers from FDA_OrangeBook_get_patent_info | Only metadata available via API; full data needs Orange Book file download |
| Using `FDAGSRS_get_structure` for biologics | Returns error; only works for chemical substances |
| Not passing `ttys="IN"` to RxClass_get_class_members | May return branded products; "IN" restricts to active ingredients |
| Using `overall_status` as string in search_clinical_trials | Must be array: `["RECRUITING"]` not `"RECRUITING"` |

---

## Reasoning Framework

### Evidence Grading

| Tier | Description | Example |
|------|-------------|---------|
| **T1** | FDA-approved with full NDA, post-market safety established | Atorvastatin (NDA020702), decades of real-world data |
| **T2** | FDA-approved but limited post-market data (new NDA or 505(b)(2)) | Recently approved novel entity, <5 years on market |
| **T3** | ANDA-approved generic or biosimilar, therapeutic equivalence demonstrated | Generic atorvastatin (ANDA, TE code AB) |
| **T4** | Investigational or foreign-only, no FDA approval | Clinical trial phase compound, not in Orange Book |

### Interpretation Guidance

**Approval pathways**: A 505(b)(1) NDA is a full new drug application with complete safety/efficacy data from the sponsor. A 505(b)(2) NDA relies partly on published literature or FDA findings for an already-approved drug (common for reformulations, new routes). An ANDA (Abbreviated NDA) is the generic pathway requiring only bioequivalence to the reference listed drug.

**Orange Book patent and exclusivity**: NCE (New Chemical Entity) exclusivity gives 5 years of data protection. ODE (Orphan Drug Exclusivity) gives 7 years. PED (Pediatric) adds 6 months to existing patents/exclusivity. A TE code of "AB" means the generic is therapeutically equivalent and substitutable. No TE code or "BX" means substitutability is not established.

**DailyMed label sections**: The "Adverse Reactions" section distinguishes clinical trial rates (controlled) from post-marketing reports (uncontrolled, signal-only). "Contraindications" are absolute; "Warnings and Precautions" are conditional risks. "Clinical Pharmacology" provides PK parameters (Cmax, AUC, half-life) essential for drug interaction and dosing assessment.

### Synthesis Questions

A complete drug regulatory report should answer:
1. What is the current FDA approval status and pathway (NDA vs ANDA vs 505(b)(2))?
2. Are generic equivalents available, and what is their therapeutic equivalence rating?
3. When do key patents and exclusivities expire (or have they already)?
4. What drug class does this belong to (ATC, EPC, MoA), and what are peer drugs in the class?
5. What are the most clinically significant adverse reactions and contraindications from the label?

---

## Limitations

- `FDA_OrangeBook_get_patent_info` does not return specific patent numbers or expiration dates via API.
- `FDAGSRS_get_structure` returns error for proteins, nucleic acids, polymers, and mixtures.
- `DailyMed_parse_*` tools require valid drug name or SPL Set ID; some drugs have multiple labels.
- `RxClass` covers FDA-marketed drugs only; experimental or foreign-only drugs may not appear.
- `FDA_OrangeBook_*` covers FDA-approved drugs only; does not include OTC monograph products.
- `search_clinical_trials` `total_count` may be None; check `len(studies)` instead.
